Seer (SEER) Times Interest Earned (2020 - 2026)
Seer (SEER) recorded quarterly Times Interest Earned of -$253.76 in Q1 2026, up 34.31% quarter-over-quarter from -$386.33 in Q4 2025, and down 827.86% on a YoY basis from $34.86 in Q1 2025.
Seer (SEER) Times Interest Earned (2020 - 2026) Analysis & Trends
Seer's Times Interest Earned history runs 7 years deep, the most recent figure standing at -$253.76 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 827.86% year-over-year to -$253.76; the TTM figure through Mar 2026 stood at -$230.7 (down 1755.05% YoY), while the FY2025 annual figure was -$77.22, down 77.26% from the prior year.
- Times Interest Earned was -$253.76 for Q1 2026 at Seer, up from -$386.33 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $219.91 in Q4 2023 to a low of -$5946.5 in Q1 2022.
- Historically, Times Interest Earned has averaged -$756.13 across 5 years, with a median of -$297.77 in 2022.
- Biggest YoY gain for Times Interest Earned was 164.34% in 2023; the steepest drop was 1951.85% in 2023.
- A 5-year view of Times Interest Earned shows it stood at -$341.77 in 2022, then jumped by 164.34% to $219.91 in 2023, then plunged by 496.69% to -$872.34 in 2024, then surged by 55.71% to -$386.33 in 2025, then jumped by 34.31% to -$253.76 in 2026.
- The last three Times Interest Earned figures came in at -$253.76 (Q1 2026), -$386.33 (Q4 2025), and -$92.12 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -258.33 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 11.79 |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | -253.76 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -253.76 |
| Dec 31, 2025 | -386.33 |
| Sep 30, 2025 | -92.12 |
| Mar 31, 2025 | -27.35 |
| Dec 31, 2024 | -872.34 |
| Sep 30, 2024 | -108.59 |
| Jun 30, 2024 | -144.90 |
| Mar 31, 2024 | -345.10 |
| Dec 31, 2023 | 219.91 |
| Sep 30, 2023 | -2,584.50 |
| Jun 30, 2023 | -558.82 |
| Mar 31, 2023 | -118.81 |
| Dec 31, 2022 | -341.77 |
| Sep 30, 2022 | -125.96 |
| Jun 30, 2022 | -411.12 |
| Mar 31, 2022 | -5,946.50 |
| Dec 31, 2021 | -903.36 |
| Dec 31, 2020 | 1,449.00 |
| Sep 30, 2020 | -935.11 |